Design, Synthesis, and Invitro Pharmacological Evaluation of Novel Resveratrol Surrogate Molecules against Alzheimer's Disease
Chemistry & Biodiversity · 2024
DOI: 10.1002/cbdv.202401430 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Arunkumar Subramanian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Tamilnadu, 603203, India. Hauptthemen laut MEDLINE: Acetylcholinesterase, Alzheimer Disease, Antioxidants, Butyrylcholinesterase. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
A series of resveratrol surrogate molecules were designed, synthesized and biologically evaluated for inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) along with anti‐oxidant activity as potential novel multifunctional agents against Alzheimer's disease (AD). Six novel compounds were synthesized by reacting (E)‐4‐(3,5‐Dimethoxystyryl) aniline with benzaldehyde and some selected derivatives of benzaldehyde in the presence of ethanol and a few drops of glacial acetic acid which followed the general scheme involved in the formation of Schiff bases. The spectral analysis data including FT‐IR, 1 H‐NMR, 13 C‐NMR, and Mass spectroscopy results were found to be in good agreement with the newly synthesized compounds (Resveratrol Surrogate Molecules 1–6). The synthesized compounds were evaluated for their dual cholinesterase inhibitory activities, cytotoxic effect, and anti‐oxidant potential. The results showed that compound RSM5 showed potent inhibitory activity against AChE and BChE. In, addition the cytotoxicity of the compound RSM5 is less and found to be within the desirable limit indicating the potential safety of RSM5. Also, it possesses substantial anti‐oxidant activity which qualifies RSM5 as an anti‐AD agent. Taken together, these findings demonstrate that the molecule RSM5 had the most multifunctional properties and could be a promising lead molecule for the future development of drugs for Alzheimer's treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Tamilnadu, 603203, India.
- Department of Parasitology & Medical Entomology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Cheras, 56000, Kuala Lumpur, Malaysia.
- School of Pharmacy, Monash University Malaysia, Bandar Sunway, Subang Jaya, 47500, Selangor, Malaysia.
- Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Subang Jaya, 47500, Selangor, Malaysia.
- Faculty of Health and Life Sciences, INTI International University, Nilai, 71800, Malaysia.
ORCID-Profile: Tamilanban T
Zitieren
APA
Subramanian, A., T, T., Kumarasamy, V., Sekar, M., Subramaniyan, V., & Wong, L. S. (2024). Design, Synthesis, and Invitro Pharmacological Evaluation of Novel Resveratrol Surrogate Molecules against Alzheimer's Disease. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401430
Vancouver
Subramanian A, T T, Kumarasamy V, Sekar M, Subramaniyan V, Wong LS. Design, Synthesis, and Invitro Pharmacological Evaluation of Novel Resveratrol Surrogate Molecules against Alzheimer's Disease. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202401430
BibTeX
@article{Subramanian2024,
author = {Subramanian, Arunkumar and T, Tamilanban and Kumarasamy, Vinoth and Sekar, Mahendran and Subramaniyan, Vetriselvan and Wong, Ling Shing},
title = {Design, Synthesis, and Invitro Pharmacological Evaluation of Novel Resveratrol Surrogate Molecules against Alzheimer's Disease},
journal = {Chemistry & Biodiversity},
year = {2024},
doi = {10.1002/cbdv.202401430}
}
EUVIMED